000069190 001__ 69190
000069190 005__ 20160817105452.0
000069190 022__ $$a1543-9135
000069190 022__ $$a1543-9143
000069190 0247_ $$2ZDBID$$aPERI:(DE-600)2449017-9
000069190 0247_ $$2ZDBPPN$$aZDPPN:990273695
000069190 0247_ $$2OCLC$$aOCLC:645385105
000069190 0247_ $$2SCOPUS$$aSCOPUS:19200156925
000069190 0247_ $$2Medline$$amedline:101174596
000069190 035__ $$aPERI:(DE-600)2449017-9
000069190 041__ $$aeng
000069190 082__ $$a610
000069190 2100_ $$2iso$$aCancer Ther
000069190 2100_ $$2dnlm$$aCancer Ther
000069190 2100_ $$2iso$$aCancer Ther
000069190 245__ $$aCancer therapy$$honline
000069190 247__ $$2DE-600$$aCancer therapy
000069190 260__ $$aMountain View, Calif. [u.a.]$$bGene Therapy Press
000069190 380__ $$2marcgt$$ajournal
000069190 500__ $$aAutomatically generated record. (Updated: 08/2016)
000069190 650_7 $$0ASJC:3004$$2ASJC$$aPharmacology
000069190 650_7 $$0ASJC:2730$$2ASJC$$aOncology
000069190 650_7 $$0ASJC:1306$$2ASJC$$aCancer Research
000069190 8564_ $$uhttp://ezb.uni-regensburg.de/2449017$$yEZB
000069190 909CO $$ooai:juser.fz-juelich.de:157482$$pauthority$$pauthority:PERI
000069190 909CO $$ooai:juser.fz-juelich.de:157482
000069190 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000069190 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000069190 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000069190 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000069190 980__ $$aPERI
000069190 980__ $$aAUTHORITY